Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-30

Clinical Trial Update: The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating how tapering pace and certain traits influence discontinuation of hypnotics in individuals with hypnotic dependence and insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Jewish Health | Conditions: Hypnotic Dependence Among Those With Insomnia | Phase 2 | Status: COMPLETED